Hedge Fund and Insider Trading News: Dan Loeb, Joel Greenblatt, Alcur Select, Harmony Biosciences Holdings Inc (HRMY), Pacific Biosciences of California Inc (PACB), and More

Page 2 of 2

Synopsys Inc (SNPS) Co-CEO & President Chi-foon Chan Sold $42.1 million of Shares (Guru Focus)
Co-CEO & President of Synopsys Inc, Chi-foon Chan, sold 198,961 shares of SNPS on 08/21/2020 at an average price of $211.79 a share. The total sale was $42.1 million. Synopsys Inc is a software development company. It supplies electronic design automation software used by engineers to design and test integrated circuits. It provides software and hardware used to develop the electronic systems that incorporate chips.

Buying Report: HRMY, CBFV (Nasdaq.com)
At Harmony Biosciences Holdings, a filing with the SEC revealed that on Monday, Director Jack Nielsen bought 37,957 shares of HRMY, at a cost of $27.58 each, for a total investment of $1.05M. So far Nielsen is in the green, up about 23.3% on their purchase based on today’s trading high of $34.00. Harmony Biosciences Holdings is trading off about 0.4% on the day Tuesday. And on Friday, Director John J. Lacarte bought $428,874 worth of CB Financial Services, buying 23,500 shares at a cost of $18.25 each. Before this latest buy, Lacarte bought CBFV on 7 other occasions during the past twelve months, for a total investment of $107,532 at an average of $24.37 per share. CB Financial Services is trading up about 2.2% on the day Tuesday. So far Lacarte is in the green, up about 3.3% on their buy based on today’s trading high of $18.85.

What Did This CEO Just Do with Personal Shares of Pacific Biosciences (NASDAQ: PACB)? (Analyst Ratings)
Yesterday, the CEO & President of Pacific Biosciences (PACB), Michael Hunkapiller, sold shares of PACB for $2.9M. Following Michael Hunkapiller’s last PACB Sell transaction on February 20, 2020, the stock climbed by 2.2%.

Only Fifteen Dow Components With Recent Insider Buying, Pfizer Is One Of Them (Forbes)
The officers and directors of a company tend to have a unique inside view into the business, so when these insiders make purchases, investors are wise to take notice. Presumably the only reason for a company insider to choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money – maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. Within the 30 components of the Dow Jones Industrial Average, only fifteen companies have experienced such buying over the trailing six month period, one of which was Pfizer, where an investment totaling $501.1K was made by Director Ronald E. Blaylock.

Cloudflare Inc (NET) CEO & Chair of the Board Matthew Prince Sold $6.2 million of Shares (Guru Focus)
CEO & Chair of the Board of Cloudflare Inc, Matthew Prince, sold 157,155 shares of NET on 08/24/2020 at an average price of $39.16 a share. The total sale was $6.2 million. Cloudflare Inc has a market cap of $11.65 billion; its shares were traded at around $38.09 with and P/S ratio of 24.64. GuruFocus has detected 1 severe warning sign with Cloudflare Inc.






Page 2 of 2